Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2011, Pages

  Karadeniz, Ali ^a   Simsek, Nejdet ^a   Karakus, Emre ^a   Yildirim, Serap ^b   Kara, Adem ^a   Can, Ismail ^a   Kisa, Fikrullah ^a   Emre, Habib ^c   Turkeli, Mehmet ^b  

^a ATATÜRK UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE SIDE EFFECTS; ANTIAPOPTOTIC ACTIVITIES; APOPTOTIC ACTIVITY; APOPTOTIC CELLS; BODY WEIGHT; CIS-PLATIN; CONTROL GROUPS; CYTOTOXIC AGENTS; DEGENERATIVE CHANGES; FOUR-GROUP; GLUTATHIONE PEROXIDASE; GLUTATHIONE-S-TRANSFERASE; GLUTATHIONES; HEPATOCYTES; HEPATOTOXICITY; HISTOLOGICAL CHANGES; KIDNEY TISSUES; LIPID PEROXIDATION; MALONDIALDEHYDE; NEPHROTOXICITY; PROTECTIVE EFFECTS; ROYAL JELLY; SINGLE-DOSE; SPRAGUE-DAWLEY RATS; STRESS PARAMETER; SUPEROXIDE DISMUTASE ACTIVITIES; TUBULAR EPITHELIUM;

ALDEHYDES; CELL DEATH; CHEMOTHERAPY; OXIDATIVE STRESS; OXYGEN; PEPTIDES; RATS; TISSUE;

PLATINUM COMPOUNDS;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; ROYAL JELLY; SUPEROXIDE DISMUTASE; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; KIDNEY; LIPID PEROXIDATION; LIVER; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; CYTOLOGY; METABOLISM;

RATTUS;

ANIMALS; APOPTOSIS; CISPLATIN; FATTY ACIDS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS;

EID: 80053508411     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2011/981793     Document Type: Article

References (63)

1. Weijl N. I., Cleton F. J., Osanto S., Free radicals and antioxidants in chemotherapy-induced toxicity Cancer Treatment Reviews 1997 23 4 209 240 (Pubitemid 27464149)
2. Kuhlmann M. K., Burkhardt G., Khler H., Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application Nephrology Dialysis Transplantation 1997 12 12 2478 2480 (Pubitemid 27520658)
3. Baliga R., Zhang Z., Baliga M., Ueda N., Shah S. V., Role of cytochrome P-450 as a source of catalytic iron in cisplatin- induced nephrotoxicity Kidney International 1998 54 5 1562 1569 (Pubitemid 28502898)
4. Silici S., Ekmekcioglu O., Kanbur M., Deniz K., The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats World Journal of Urology 2010 29 1 127 132
5. Liu J., Liu Y., Habeebu S. S. M., Klaassen C. D., Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity Toxicology and Applied Pharmacology 1998 149 1 24 31 (Pubitemid 28105569)
6. Martins N. M., Santos N. A. G., Curti C., Bianchi M. L., Santos M. C., Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver Journal of Applied Toxicology 2008 28 3 337 344 (Pubitemid 351518121)
7. Halliwell B., Gutteridge J. M. C., Halliwell B., Gutteridge J. M. C., Lipid peroxidation: a radical chain reaction Free Radicals in Biology and Medicine 1999 Oxford, UK Oxford Clarendon Press 188 276
8. Conklin K. A., Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects Nutrition and Cancer 2000 37 1 1 18 (Pubitemid 30650661)
9. Coyle J. T., Puttfarcken P., Oxidative stress, glutamate, and neurodegenerative disorders Science 1993 262 5134 689 695 (Pubitemid 23350687)
10. Valko M., Rhodes C. J., Moncol J., Izakovic M., Mazur M., Free radicals, metals and antioxidants in oxidative stress-induced cancer Chemico-Biological Interactions 2006 160 1 1 40 (Pubitemid 43227479)
11. Atessahin A., Yilmaz S., Karahan I., Ceribasi A. O., Karaoglu A., Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats Toxicology 2005 212 2-3 116 123 (Pubitemid 40981968)
12. Yousef M. I., Saad A. A., El-Shennawy L. K., Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats Food and Chemical Toxicology 2009 47 6 1176 1183
13. Yapar K., avuolu K., Oru E., Yalin E., Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study Journal of Medicinal Food 2009 12 5 1136 1142
14. Iraz M., Ozerol E., Gulec M., Tasdemir S., Idiz N., Fadillioglu E., Naziroglu M., Akyol O., Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat Cell Biochemistry and Function 2006 24 4 357 361 (Pubitemid 44065240)
15. Cemek M., Aymelek F., Bykokurolu M. E., Protective potential of Royal Jelly against carbon tetrachloride induced-toxicity and changes in the serum sialic acid levels Food and Chemical Toxicology 2010 48 10 2827 2832
16. Nakajima Y., Tsuruma K., Shimazawa M., Mishima S., Hara H., Comparison of bee products based on assays of antioxidant capacities BMC Complementary and Alternative Medicine 2009 9, article no. 4
17. Takaki-Doi S., Hashimoto K., Yamamura M., Kamei C., Antihypertensive activities of royal jelly protein hydrolysate and its fractions in spontaneously hypertensive rats Acta Medica Okayama 2009 63 1 57 64
18. Guo H., Saiga A., Sato M., Miyazawa I., Shibata M., Takahata Y., Morimatsu F., Royal jelly supplementation improves lipoprotein metabolism in humans Journal of Nutritional Science and Vitaminology 2007 53 4 345 348 (Pubitemid 47442355)
19. Chan Q. W. T., Melathopoulos A. P., Pernal S. F., Foster L. J., The innate immune and systemic response in honey bees to a bacterial pathogen, Paenibacillus larvae BMC Genomics 2009 10, article no. 387
20. Oka H., Emori Y., Kobayashi N., Hayashi Y., Nomoto K., Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses International Immunopharmacology 2001 1 3 521 532 (Pubitemid 32197549)
21. Kohno K., Okamoto I., Sano O., Arai N., Iwaki K., Ikeda M., Kurimoto M., Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages Bioscience, Biotechnology and Biochemistry 2004 68 1 138 145 (Pubitemid 39251576)
22. Okamoto I., Taniguchi Y., Kunikata T., Kohno K., Iwaki K., Ikeda M., Kurimoto M., Major royal jelly protein 3 modulates immune responses in vitro and in vivo Life Sciences 2003 73 16 2029 2045 (Pubitemid 36930038)
23. imek N., Karadeniz A., Bayraktarolu A. G., Effects of L-carnitine, royal jelly and pomegranate seed on peripheral blood cells in rats Kafkas Universitesi Veteriner Fakultesi Dergisi 2009 15 1 63 69
24. Kanbur M., Eraslan G., Beyaz L., Silici S., Liman B. C., Altinordulu., Atasever A., The effects of royal jelly on liver damage induced by paracetamol in mice Experimental and Toxicologic Pathology 2009 61 2 123 132
25. Wyllie A. H., Apoptosis: an overview British Medical Bulletin 1997 53 3 451 465 (Pubitemid 27397303)
26. Salvesen G. S., Dixit V. M., Caspases: intracellular signaling by proteolysis Cell 1997 91 4 443 446 (Pubitemid 27508233)
27. Zhan Y., van de Water B., Wang Y., Stevens J. L., The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cells Oncogene 1999 18 47 6505 6512
28. Kang M. H., Reynolds C. P., BcI-2 Inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy Clinical Cancer Research 2009 15 4 1126 1132
29. Gasic S., Vucevic D., Vasilijic S., Evaluation of the immunomodulatory activities of royal jelly components in vitro Immunopharmacology and Immunotoxicology 2007 29 3-4 521 536 (Pubitemid 350261189)
30. Arafa H. M. M., Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids Toxicology 2008 254 1-2 51 60
31. Cayir K., Karadeniz A., Yildirim A., Kalkan Y., Karakoc A., Keles M., Tekin S. B., Protective effect of L-carnitine against cisplatin-induced liver and kidney oxidant injury in rats Central European Journal of Medicine 2009 4 2 184 191
32. Khan E., Batuman V., Lertora J. J. L., Emergence of biomarkers in nephropharmacology Biomarkers in Medicine 2010 4 6 805 814
33. Greggi Antunes L. M., Darin J. D. A. C., Bianchi M. D. L. P., Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats Pharmacological Research 2001 43 2 145 150 (Pubitemid 32601443)
34. Parlakpinar H., Sahna E., Ozer M. K., Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury Journal of Pineal Research 2002 33 3 161 166
35. Mora L. D. O., Antunes L. M. G., Francescato H. D. C., Bianchi M. D. L. P., The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats Pharmacological Research 2003 47 6 517 522 (Pubitemid 36542930)
36. Sallie R., Tredger J. M., Williams R., Drugs and the liver Biopharmaceutics and Drug Disposition 1991 12 4 251 259
37. Schinella G. R., Tournier H. A., Prieto J. M., Mordujovich De Buschiazzo P., Ros J. L., Antioxidant activity of anti-inflammatory plant extracts Life Sciences 2002 70 9 1023 1033 (Pubitemid 34085094)
38. Goldstein R. S., Mayor G. H., Minireview the nephrotoxicity of cisplatin Life Sciences 1983 32 7 685 690
39. Lieber C. S., Cytochrome P-4502E1: its physiological and pathological role Physiological Reviews 1997 77 2 517 544 (Pubitemid 27184347)
40. Safirstein R. L., Lessons learned from ischemic and cisplatin-induced nephrotoxicity in animals Renal Failure 1999 21 3-4 359 364 (Pubitemid 29318203)
41. Tamura S., Kono T., Harada C., Yamaguchi K., Moriyama T., Estimation and characterisation of major royal jelly proteins obtained from the honeybee Apis merifera Food Chemistry 2009 114 4 1491 1497
42. Weijl N. I., Hopman G. D., Wipkink-Bakker A., Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients Annals of Oncology 1998 9 12 1331 1337 (Pubitemid 29045573)
43. Al-Majed A. A., Sayed-Ahmed M. M., Al-Yahya A. A., Aleisa A. M., Al-Rejaie S. S., Al-Shabanah O. A., Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model Pharmacological Research 2006 53 3 278 286 (Pubitemid 43247541)
44. Aleisa A. M., Al-Majed A. A., Al-Yahya A. A., Al-Rejaie S. S., Bakheet S. A., Al-Shabanah O. A., Sayed-Ahmed M. M., Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues Clinical and Experimental Pharmacology and Physiology 2007 34 12 1252 1259 (Pubitemid 350013238)
45. avuolu K., Yapar K., Yalin E., Royal jelly (honey bee) is a potential antioxidant against cadmium-induced genotoxicity and oxidative stress in albino mice Journal of Medicinal Food 2009 12 6 1286 1292
46. Wetzel C. C., Berberich S. J., p53 binds to cisplatin-damaged DNA Biochimica et Biophysica Acta 2001 1517 3 392 397 (Pubitemid 32126592)
47. Cummings B. S., Schnellmann R. G., Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways Journal of Pharmacology and Experimental Therapeutics 2002 302 1 8 17 (Pubitemid 34680415)
48. Lieber J., Kirchner B., Eicher C., Warmann S. W., Seitz G., Fuchs J., Armeanu-Ebinger S., Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells Pediatric Blood and Cancer 2010 55 6 1089 1095
49. Safirstein R., Miller P., Guttenplan J. B., Uptake and metabolism of cisplatin by rat kidney Kidney International 1984 25 5 753 758 (Pubitemid 14082180)
50. Kroemer G., The proto-oncogene Bcl-2 and its role in regulating apoptosis Nature Medicine 1997 3 6 614 620 (Pubitemid 27264969)
51. Walker A., Taylor S. T., Hickman J. A., Dive C., Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells Cancer Research 1997 57 10 1939 1945 (Pubitemid 27209725)
52. Reed J. C., Double identity for proteins of the Bcl-2 family Nature 1997 387 6635 773 776 (Pubitemid 27270895)
53. Yin D. X., Schimke R. T., BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells Cancer Research 1995 55 21 4922 4928
54. Salvesen G. S., Dixit V. M., Caspases: intracellular signaling by proteolysis Cell 1997 91 4 443 446 (Pubitemid 27508233)
55. Blachley J. D., Hill J. B., Renal and electrolyte disturbances associated with cisplatin Annals of Internal Medicine 1981 95 5 628 632 (Pubitemid 12231806)
56. Lau A. H., Apoptosis induced by cisplatin nephrotoxic injury Kidney International 1999 56 4 1295 1298 (Pubitemid 29451234)
57. Mller M., Strand S., Hug H., Heinemann E. M., Walczak H., Hofmann W. J., Stremmel W., Krammer P. H., Galle P. R., Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO- 1/Fas) receptor/ligand system and involves activation of wild-type p53 Journal of Clinical Investigation 1997 99 3 403 413 (Pubitemid 27414797)
58. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Analytical Biochemistry 1979 95 2 351 358 (Pubitemid 9194347)
59. Tietze F., Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Analytical Biochemistry 1969 27 3 502 522
60. Anderson M. E., Determination of glutathione and glutathione disulfide in biological samples Methods in Enzymology 1985 113 548 555 (Pubitemid 16195830)
61. Paglia D. E., Valentine W. N., Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase The Journal of Laboratory and Clinical Medicine 1967 70 1 158 169
62. Habig W. H., Pabst M. J., Jakoby W. B., Glutathione S transferases. The first enzymatic step in mercapturic acid formation Journal of Biological Chemistry 1974 249 22 7130 7139
63. Sun Y., Oberley L. W., Li Y., A simple method for clinical assay of superoxide dismutase Clinical Chemistry 1988 34 3 497 500